Cognition Therapeutics
CGTX
CGTX
40 hedge funds and large institutions have $1.99M invested in Cognition Therapeutics in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
77% less capital invested
Capital invested by funds: $8.82M → $1.99M (-$6.82M)
Holders
40
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$92.8K | |
| 2 | +$64K | |
| 3 | +$44.6K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$37K |
| 5 |
VF
Virtu Financial
New York
|
+$27K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$600K | |
| 3 | -$499K | |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
-$232K |
| 5 |
CCM
Corsair Capital Management
New York
|
-$129K |